Developer Responds to Concerns Over Manhattan Building

The developer of a Manhattan skyscraper, which recently faced evacuation due to concerns over structural damage, claims that the situation has been overstated. They assert that the issues are confined to a small area of the building and that there was never any actual risk of collapse.

Metroloft released a statement indicating that they are collaborating with the New York City Department of Buildings to assess and address the matter. They emphasized that the building is currently stable and assured the public that plans are in place to resolve the concerns.

According to Metroloft, “This is a localized situation, affecting less than 30 of the more than 1,600 apartments. At no point was the building or any part of it in imminent danger.”

Emergency personnel discovered two buckled support columns and sagging floors in the 37-story structure, prompting evacuations of nearby buildings and construction crews on Tuesday.

Nathan Berman, founder of Metroloft, mentioned in an interview that reports of an imminent collapse were somewhat exaggerated. He described the building as a large project with a robust foundation, adding that the damage is limited to a small section and is “very repairable.”

Fire officials had initially raised alarms about the potential for an “extremely dangerous situation.” However, their primary concern shifted to a localized collapse rather than the failure of the entire structure.

After emergency crews worked to stabilize the building overnight, the Mayor noted that no further movement had been detected and pledged to look into the cause of the problems.

Berman speculated that the damage may have been caused by the added weight from converting office spaces into residential units, dubbing it a “freak accident” due to insufficient reinforcement or unnoticed defects in the supports. He insisted there was no mystery to the situation.

Responding to union concerns regarding structural integrity, Berman dismissed those claims, calling them unfounded and emphasizing that the project had been designed and vetted by structural engineers.

This project aims to transform Pfizer’s former headquarters into roughly 1,600 apartment units, marking it as the largest office-to-residential conversion in New York City to date.

Berman expressed confidence that by addressing the structural issues, the project would still meet its intended completion date in 2027.